
URI, Yale researchers find promising cancer treatment
First trial phase to take place at Memorial Sloan Kettering Cancer Center Pictured: Samples under microscope used to identify cancer. PHOTO CREDIT: uri.edu Professors at the University of Rhode Island are working in collaboration with Yale University and Memorial Sloan Kettering Cancer Center (MSKCC) on a new peptide that has been designed to target cancerous…